| License: Creative Commons Attribution Non-commercial No Derivatives 4.0 PDF - Published Version Early View (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-492510
- DOI to cite this document:
- 10.5283/epub.49251
Abstract
Background Extracorporeal photopheresis (ECP), an apheresis-based therapy for various immunological diseases, works mainly by inducing apoptosis in lymphocytes. Several factors influence the efficacy of ECP with the photosensitizer 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA). This study aimed to optimize treatment by varying the 8-MOP starting concentration and the cell suspension ...

Owner only: item control page